In two recent studies, Smith, Su, Wallach et al. engineered a safer version of Bacille Calmette–Guerin with strong protection against Mycobacterium tuberculosis, while Wang, Su, Wallach, Wagner et al. developed an engineered M. tuberculosis strain as a candidate for human challenge studies.